Prevalence of mental health problems during the COVID-19 pandemic: A systematic review and meta-analysis
| Autor: | Xiaoqian Jia, Xiaohan Yin, Jieqiong Niu, Tianchen Wu, Jialei Xie, Huifeng Shi, Xiaoli Wang |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2021 |
| Předmět: |
medicine.medical_specialty
Insomnia Health Personnel Psychological intervention Review Article Anxiety Psychological Distress 03 medical and health sciences 0302 clinical medicine Sleep Initiation and Maintenance Disorders Health care Pandemic Prevalence Medicine Humans Noncommunicable Diseases Pandemics Depression (differential diagnoses) business.industry Depression Distress COVID-19 Mental health 030227 psychiatry Psychiatry and Mental health Clinical Psychology Mental Health Meta-analysis Family medicine Chronic Disease Quarantine Systemic review medicine.symptom business 030217 neurology & neurosurgery |
| Zdroj: | Journal of Affective Disorders |
| ISSN: | 0165-0327 |
| DOI: | 10.1016/j.jad.2020.11.117 |
| Popis: | Highlinghts • The COVID-19 pandemic increases the prevalence of depression, anxiety, distress, and insomnia. • Health care workers and COVID-19 patients are high-risk groups of mental health. • Urgent interventions are needed for preventing mental health problems. Background The global COVID-19 pandemic has generated major mental and psychological health problems worldwide. We conducted a meta-analysis to assess the prevalence of depression, anxiety, distress, and insomnia during the COVID-19 pandemic. Methods We searched online biomedical databases (PubMed, Embase, Web of Science, Ovid, CNKI, and Wanfang Data) and preprint databases (SSRN, bioRxiv, and MedRxiv) for observational studies from January 1, 2020 to March 16, 2020 investigating the prevalence of mental health problems during the COVID-19 pandemic. Results We retrieved 821 citations from the biomedical databases and 53 citations from the preprint databases: 66 studies with 221,970 participants were included in our meta-analysis. The overall pooled prevalence of depression, anxiety, distress, and insomnia was 31.4%, 31.9%, 41.1% and 37.9%, respectively. Noninfectious chronic disease patients, quarantined persons, and COVID-19 patients had a higher risk of depression (Q=26.73, p |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect